Author

Meghan K. Herring

Observed names: Meghan Herring, Meghan K Herring

Institutions: Marshfield Clinic, University of Arizona, University of Utah, Marshfield Clinic, University of Utah Health Care

Observed institutions: Centers for Disease Control and Prevention, Marshfield Clinic, University of Arizona, University of Miami, Emory University, University of Utah, Schulman, Ronca & Bucuvalas, Marshfield Clinic, University of Utah Health Care, Abt Global (United States), Baylor Scott & White Health, Texas A&M University

ORCID: 0000-0002-4267-4033

Observed ORCID: 0000-0002-4267-4033

OpenAlex ID: A5003883297

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

2021 · Mark G. Thompson, Jefferey L. Burgess, et al. · MMWR Morbidity and Mortality Weekly Report · 710

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

2021 · Mark G. Thompson, Jefferey L. Burgess, et al. · New England Journal of Medicine · 483

Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers

2022 · The HEROES-RECOVER Network, Gregory Joseph, et al. · JAMA · 36

Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): Protocol for a Multisite Longitudinal Cohort Study

2021 · Laura J Edwards, Ashley L Fowlkes, et al. · JMIR Research Protocols · 27

COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers

2021 · Karen Lutrick, Holly Groom, et al. · Vaccine · 26

Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers

2023 · Katherine D. Ellingson, James Hollister, et al. · Emerging infectious diseases · 17

Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection

2021 · Harmony L Tyner, Jefferey L Burgess, et al. · Clinical Infectious Diseases · 13

Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study

2022 · Joy Burns, Patrick Rivers, et al. · JMIR Research Protocols · 11

Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses

2022 · Meghan K Herring, James K Romine, et al. · Clinical Infectious Diseases · 8

Exploring Spatial Differences Between 2 US Firearm Mortality Data Sets in 2017

2020 · Meghan K. Herring, Cassandra A. Kersten · Preventing Chronic Disease · 3

Pediatric Research Observing Trends and Exposures in COVID-19 Timelines (PROTECT): Protocol for a Multisite Longitudinal Cohort Study (Preprint)

2022 · Joy Burns, Patrick Rivers, et al.

Works count: 11

Citation count: 1,333

H-index: 8

I10-index: 8